11 patents
Utility
Prevention or Treatment of Disease States Due to Metal Dis-homeostasis Via Administration of Posiphen to Healthy or Sick Humans
9 Nov 23
The invention relates in part to a method of maintaining heavy metal homeostasis in healthy humans, comprising chronically administering to healthy humans a pharmaceutical composition consisting of from about 1 mg to less than about 200 mg of Posiphen or a pharmaceutically acceptable salt thereof together with one or more pharmaceutically acceptable excipients, on a once a day basis.
Maria Maccecchini
Filed: 6 Mar 23
Utility
Prevention or treatment of disease states due to metal dis-homeostasis via administration of Posiphen to healthy or sick humans
7 Mar 23
The invention relates in part to a method of maintaining heavy metal homeostasis in healthy humans, comprising chronically administering to healthy humans a pharmaceutical composition consisting of from about 1 mg to less than about 200 mg of Posiphen or a pharmaceutically acceptable salt thereof together with one or more pharmaceutically acceptable excipients, on a once a day basis.
Maria Maccecchini
Filed: 23 Mar 20
Utility
Inhibition of Neurological Injuries Due to Infections Via Administration of Butanetap and Analogs Thereof
24 Nov 22
The invention relates to methods of inhibiting or treating neurological damage in a human who is infected by or at risk of infection by a virus, a bacterium, a fungus, a protozoan or a parasite that can cause neurological damage, comprising administering to a human a compound selected from the group consisting of Formula (I), Formula (II), Formula (III) or Formula (IV) or pharmaceutically acceptable salts thereof.
Maria Maccecchini
Filed: 17 May 22
Utility
(3AR)-1,3A,8-TRIMETHYL-1 ,2,3,3A,8,8AHEXAHYDROPYRROLO[2,3-B]INDOL-5-YL Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
13 Oct 22
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 7 Jun 22
Utility
(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
2 Aug 22
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 17 Aug 20
Utility
(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
12 Jul 22
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 17 Aug 20
Utility
(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
5 Jul 22
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 17 Aug 20
Utility
(3AR)-1,3A,8-trimethyl-1,2,3,3A,8,8A-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
24 Aug 21
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 8 Jul 19
Utility
(3AR)-1,3A,8-TRIMETHYL-1 ,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
1 Apr 21
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 17 Aug 20
Utility
(3AR)-1,3A,8-TRIMETHYL-1 ,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
2 Dec 20
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 16 Aug 20
Utility
(3AR)-1,3A,8-TRIMETHYL-1 ,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
2 Dec 20
The invention includes an amount of (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate for administering to a subject and also a method of preventing or treating neurotoxicity or neurodegenerative processes in a subject in need thereof using the amount thereof.
Maria Maccecchini
Filed: 16 Aug 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first